Your browser doesn't support javascript.
loading
The Association Between Hematologic Indices With TIMI Flow In STEMI Patients Who Undergo primary percutaneous coronary intervention.
Parsa, Saeed Alipour; Nourian, Saeed; Safi, Morteza; Namazi, Mohammad Hasan; Saadat, Habib; Vakili, Hossein; Eslami, Vahid; Salehi, Ayoub; Kiaee, Farshid Heidarpour; Sohrabifar, Nasim; Khaheshi, Isa.
Afiliación
  • Parsa SA; Cardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Nourian S; Cardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Safi M; Cardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Namazi MH; Cardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Saadat H; Cardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Vakili H; Cardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Eslami V; Cardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Salehi A; Cardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Kiaee FH; Cardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Sohrabifar N; Cardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Khaheshi I; Cardiovascular Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Article en En | MEDLINE | ID: mdl-36100995

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Qualitative_research / Risk_factors_studies Idioma: En Revista: Cardiovasc Hematol Disord Drug Targets Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA / HEMATOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2022 Tipo del documento: Article País de afiliación: Irán

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Qualitative_research / Risk_factors_studies Idioma: En Revista: Cardiovasc Hematol Disord Drug Targets Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA / HEMATOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2022 Tipo del documento: Article País de afiliación: Irán